Published in Ann Intern Med on October 06, 2009
Improving Intermediate Risk Management. MARK Study (MARK) | NCT01428934
Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation (2012) 1.95
Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation (2011) 1.77
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study. JACC Cardiovasc Imaging (2012) 1.52
Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation (2011) 1.51
Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk. Circ Cardiovasc Qual Outcomes (2015) 1.40
Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA (2014) 1.36
Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment. J Am Coll Cardiol (2011) 1.15
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2014) 1.05
Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves. Curr Opin HIV AIDS (2010) 1.01
Improving interMediAte risk management. MARK study. BMC Cardiovasc Disord (2011) 0.91
Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010. Arch Pathol Lab Med (2013) 0.83
Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance. Semin Oncol (2013) 0.82
Atherosclerosis screening by noninvasive imaging for cardiovascular prevention: a systematic review. J Gen Intern Med (2011) 0.82
Coronary artery calcium and primary prevention risk assessment: what is the evidence? An updated meta-analysis on patient and physician behavior. Circ Cardiovasc Qual Outcomes (2012) 0.81
Fasting glucose, obesity, and coronary artery calcification in community-based people without diabetes. Diabetes Care (2012) 0.81
Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population. PLoS One (2014) 0.80
The role of carotid intimal thickness testing and risk prediction in the development of coronary atherosclerosis. Curr Atheroscler Rep (2013) 0.79
Applicability of the Existing CVD Risk Assessment Tools to Type II Diabetics in Oman: A Review. Oman Med J (2015) 0.77
Screening strategies for cardiovascular disease in asymptomatic adults. Prim Care (2014) 0.76
The USPSTF recommendation statement on coronary heart disease risk assessment. Ann Intern Med (2010) 0.75
The USPSTF recommendation statement on coronary heart disease risk assessment. Ann Intern Med (2010) 0.75
The USPSTF recommendation statement on coronary heart disease risk assessment. Ann Intern Med (2010) 0.75
Physical Health Indicators Improve Prediction of Cardiovascular and All-cause Mortality among Middle-Aged and Older People: a National Population-based Study. Sci Rep (2017) 0.75
The USPSTF recommendation statement on coronary heart disease risk assessment. Ann Intern Med (2010) 0.75
Observation of elevated fasting blood glucose and functional outcome after ischemic stroke in patients with and without diabetes. Oncotarget (2017) 0.75
Prediction of ventricular arrhythmia events in ischemic heart disease patients with implantable cardioverter-defibrillators. J Mater Sci Mater Med (2015) 0.75
Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann Intern Med (2009) 2.96
Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 1.85
Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 1.66
Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 1.43
Screening for syphilis infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2009) 0.89